skip to content

Investment Research For Regular People

Conflict-Free Research on Investments: Stocks, Funds, IPOs

  • 5i Research works only for you.
  • We are conflict-free.
  • Our research is independent.

No one else in the investment industry can honestly say that.

Become a Member

Peter Hodson and Ryan Modesto

5i Recent Blog Posts


Stock Screener - Revenue Growth

For this months stock market screen, we take a look at companies showing above average revenue growth.

Moez M Sep 16, 2018
5i Recent Questions

Q: Hi 5i team,
Brookfield equities (BAM, BEP and BIP) represent 8% of our portfolio. I am down 8% on BEP but am wondering whether the current dip down to $38.87 per share represents a good buying opportunity, especially given it's dividend yield at around 5.5%. So, my questions are: 1) is an 8% total Brookfield weighting too much in general, and 2) what about buying more BEP or do you think that it's likely to slide further given their broad holdings in emerging markets. Thanks for your help.

Read Answer Asked by Martha on September 24, 2018

Q: How safe would it be to invest in 370 shares of TDB3091 for a 3 month period in US funds?
Thanks for your usual quick reply.

Read Answer Asked by Terry on September 24, 2018
5i Recent Reports
Rating
B+

Review of Knight Therapeutics

SEP 19, 2018 - Specialty Pharmaceutical company focused on later stage commercialization of drugs. The company continues to hold on to a high balance of cash, waiting for the right opportunity. Despite strong fundamentals and management, the increased opportunity cost and stock trading sideways justify the rating to be downgraded one notch to 'B+'.

Download Report
Rating
C

Review of DHX Media

SEP 19, 2018 - Global children's entertainment firm facing huge headwinds. Lowered guidance, competition, high debt, and ongoing strategic review are some key negatives. Rating downgraded to 'C'.

Download Report
Rating
B+

Review of TFI International

AUG 30, 2018 - Transportation and logistics company growing through acquisition and facing a positive economic backdrop all while holding a cheap valuation. Initiating coverage at a 'B+' rating.

Download Report
Rating
B

Review of Stantec Inc

AUG 30, 2018 - Professional engineering firm with big market share facing headwinds and stagnant growth. Rating downgraded two notches to 'B'.

Download Report
Rating
B-

Review of Canaccord Genuity

AUG 27, 2018 - Independent financial services company trying to be less volatile with an increased focus towards wealth management and capitalizing on increasing number of deals in the cannabis sector. Rating upgraded a notch to 'B-'.

Download Report